Publications of A. Leonov
All genres
Journal Article (41)
41.
Journal Article
11 (11), pp. 3342 - 3348 (2005)
Convenient synthesis of multifunctional EDTA-based chiral metal chelates substituted with an S-mesylcysteine. Chemistry-A European Journal Conference Paper (6)
42.
Conference Paper
39 (Suppl), pp. 530 - 531 (2019)
In vitro evaluation of small molecule compounds as potential PET tracers targeting a-synuclein. 29th International Symposium on Cerebral Blood Flow, Metabolism and Function / 14th International Conference on Quantification of Brain Function with PET (BRAIN and BRAIN Pet), Yokohama, Japan, July 04, 2019 - July 07, 2019. Journal of Cerebral Blood Flow and Metabolism 43.
Conference Paper
The small molecule anle138b shows interaction with alpha-synuclein oligomers in phospholipid membranes. 62nd Annual Meeting of the Biophysical-Society, San Francisco, CA, February 17, 2018 - February 21, 2018. Biophysical Journal (Suppl), 3 Ed., p. 560a - 560a (2018)
44.
Conference Paper
110 (Suppl 1), 3 Ed., p. 420A - 420A (2016)
Effect of the novel amyloid inhibitor "anle145c" on aggregation of islet amyloid polypeptide and how it is modulated by membranes. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, February 27, 2016 - March 02, 2016. Biophysical Journal 45.
Conference Paper
21 (Suppl. 1), p. 170 - 170 (2014)
The oligomer modulator anle138b is effective in the prodromal phase of a transgenic mouse model of Parkinson's disease. Joint Congress of European Neurology, Istanbul, Turkey, May 31, 2014 - June 03, 2014. European Journal of Neurology 46.
Conference Paper
70 (6), p. 505 - 505 (2011)
Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. 87th Annual Meeting of the American Association of Neuropathologists, Seattle, WA, June 23, 2011 - June 26, 2011. Journal of Neuropathology and Experimental Neurology 47.
Conference Paper
26 (Supplement 2), p. S21 - S21 (2011)
Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders Patent (1)
48.
Patent
New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)
Preprint (2)
49.
Preprint
The amyloid oligomer modulator anle138b has disease modifying effects in a human IAPP transgenic mouse model of type 2 diabetes mellitus (hIAPP Ob/Ob mice). bioRxiv (2024)
50.
Preprint
[11C]MODAG 005 – a novel PET tracer targeting alpha-synuclein aggregates in the brain. Research Square (2024)